<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36582234</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?</ArticleTitle><Pagination><StartPage>1070994</StartPage><MedlinePgn>1070994</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1070994</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1070994</ELocationID><Abstract><AbstractText Label="BACKGROUND">Recovery from coronavirus disease 2019 (COVID-19) can be impaired by the persistence of symptoms or new-onset health complications, commonly referred to as Long COVID. In a subset of patients, Long COVID is associated with immune system perturbations of unknown etiology, which could be related to compromised immunoregulatory mechanisms.</AbstractText><AbstractText Label="OBJECTIVE">The objective of this scoping review was to summarize the existing literature regarding the frequency and functionality of Tregs in convalescent COVID-19 patients and to explore indications for their potential involvement in the development of Long COVID.</AbstractText><AbstractText Label="DESIGN">A systematic search of studies investigating Tregs during COVID-19 convalescence was conducted on MEDLINE (<i>via</i> Pubmed) and Web of Science.</AbstractText><AbstractText Label="RESULTS">The literature search yielded 17 relevant studies, of which three included a distinct cohort of patients with Long COVID. The reviewed studies suggest that the Treg population of COVID-19 patients can reconstitute quantitatively and functionally during recovery. However, the comparison between recovered and seronegative controls revealed that an infection-induced dysregulation of the Treg compartment can be sustained for at least several months. The small number of studies investigating Tregs in Long COVID allowed no firm conclusions to be drawn about their involvement in the syndrome's etiology. Yet, even almost one year post-infection Long COVID patients exhibit significantly altered proportions of Tregs within the CD4+ T cell population.</AbstractText><AbstractText Label="CONCLUSIONS">Persistent alterations in cell frequency in Long COVID patients indicate that Treg dysregulation might be linked to immune system-associated sequelae. Future studies should aim to address the association of Treg adaptations with different symptom clusters and blood parameters beyond the sole quantification of cell frequencies while adhering to consensualized phenotyping strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Haunhorst, Bloch, Javelle, Kr&#xfc;ger, Baumgart, Drube, Lemh&#xf6;fer, Reuken, Stallmach, M&#xfc;ller, Zielinski, Pletz, Gabriel and Puta.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haunhorst</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloch</LastName><ForeName>Wilhelm</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javelle</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kr&#xfc;ger</LastName><ForeName>Karsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Exercise Physiology and Sports Therapy, Institute of Sports Science, Justus-Liebig-University Giessen, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumgart</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Immunology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drube</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Immunology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemh&#xf6;fer</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Physiotherapy, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuken</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinic for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stallmach</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinic for Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infection Immunology, Leibniz Institue for Natural Product Research and Infection Biology, Hans Kn&#xf6;ll Institute, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zielinski</LastName><ForeName>Christina E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Department of Infection Immunology, Leibniz Institue for Natural Product Research and Infection Biology, Hans Kn&#xf6;ll Institute, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pletz</LastName><ForeName>Mathias W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Institute for Immunology, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Holger H W</ForeName><Initials>HHW</Initials><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Interdisciplinary Prevention of Diseases related to Professional Activities, Jena, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050378" MajorTopicYN="N">T-Lymphocytes, Regulatory</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">adaptive immunity</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">regulatory T cells (T reg)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>30</Day><Hour>2</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36582234</ArticleId><ArticleId IdType="pmc">PMC9792979</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1070994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. . Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med (2020) 382:NEJMoa2002032. doi:&#xa0;10.1056/nejmoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet Lond Engl (2020) 395:497&#x2013;506. doi:&#xa0;10.1016/s0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. . Extrapulmonary manifestations of COVID-19. Nat Med (2020) 26:1017&#x2013;32. doi:&#xa0;10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>White-Dzuro G, Gibson LE, Zazzeron L, White-Dzuro C, Sullivan Z, Diiorio DA, et al. . Multisystem effects of COVID-19: A concise review for practitioners. Postgrad Med (2020) 133:1&#x2013;8. doi:&#xa0;10.1080/00325481.2020.1823094</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2020.1823094</ArticleId><ArticleId IdType="pmc">PMC7651182</ArticleId><ArticleId IdType="pubmed">32921198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. New Engl J Med (2020) 383:120&#x2013;8. doi:&#xa0;10.1056/nejmoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. . On the alert for cytokine storm: Immunopathology in COVID-19. Arthritis Rheumatol Hoboken N J (2020) 72:1059&#x2013;63. doi:&#xa0;10.1002/art.41285</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41285</ArticleId><ArticleId IdType="pmc">PMC7262347</ArticleId><ArticleId IdType="pubmed">32293098</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. . Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol (2020) 11:827. doi:&#xa0;10.3389/fimmu.2020.00827</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Wang Y, Li J, Han H, Xia Z, Liu F, et al. . Decreased T cell populations contribute to the increased severity of COVID-19. Clin Chimica Acta Int J Clin Chem (2020) 508:110&#x2013;4. doi:&#xa0;10.1016/j.cca.2020.05.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.05.019</ArticleId><ArticleId IdType="pmc">PMC7219428</ArticleId><ArticleId IdType="pubmed">32405080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. . Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci (2020) 13:1077&#x2013;86. doi:&#xa0;10.1111/cts.12805</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12805</ArticleId><ArticleId IdType="pmc">PMC7264560</ArticleId><ArticleId IdType="pubmed">32315487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM, Initiative LCR . Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet (2022) 400:452&#x2013;61. doi:&#xa0;10.1016/s0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WCCDWG on p-C-19. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis (2021) 22:E102-E107. doi:&#xa0;10.1016/s1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. Eclinicalmedicine (2021) 36:100899. doi:&#xa0;10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine (2021) 38:101019. doi:&#xa0;10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep-uk (2021) 11:16144. doi:&#xa0;10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Giszas B, Trommer S, Sch&#xfc;&#xdf;ler N, Rodewald A, Besteher B, Bleidorn J, et al. . Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID. Infection (2022), 1&#x2013;13. doi:&#xa0;10.1007/s15010-022-01886-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01886-9</ArticleId><ArticleId IdType="pmc">PMC9307219</ArticleId><ArticleId IdType="pubmed">35869353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Baricich A, Patrucco F, Zeppegno P, Gramaglia C, Balbo PE, et al. . Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep-uk (2021) 11:22666. doi:&#xa0;10.1038/s41598-021-01215-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-01215-4</ArticleId><ArticleId IdType="pmc">PMC8608998</ArticleId><ArticleId IdType="pubmed">34811387</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. . 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet (2021) 398:747&#x2013;58. doi:&#xa0;10.1016/s0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S, Bloch W, Wagner H, Ellert C, Kr&#xfc;ger K, Vilser DC, et al. . Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxf Open Immunol (2022) 3:iqac006. doi:&#xa0;10.1093/oxfimm/iqac006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqac006</ArticleId><ArticleId IdType="pmc">PMC9494493</ArticleId><ArticleId IdType="pubmed">36846561</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun (2022) 13:1957. doi:&#xa0;10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med (2022) 28:1&#x2013;8. doi:&#xa0;10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. He immunology and immunopathology of COVID-19. Sci New York N Y (2022) 375:1122&#x2013;7. doi:&#xa0;10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, et al. . Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells (2021) 10:386. doi:&#xa0;10.3390/cells10020386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho H, Goldberg SA, et al. . Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis (2021) 11:1839&#x2013;48. doi:&#xa0;10.1093/infdis/jiab490</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, et al. . The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med (2022) 3:100663. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, et al. . Functional autoantibodies against g-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun (2021) 4:100100. doi:&#xa0;10.1016/j.jtauto.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, O&#x2019;Farrelly C, Tancevski I, L&#xf6;ffler-Ragg J, et al. . Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med (2022) 28:879&#x2013;82. doi:&#xa0;10.1038/s41591-022-01766-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol (2003) 4:330&#x2013;6. doi:&#xa0;10.1038/ni904</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni904</ArticleId><ArticleId IdType="pubmed">12612578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell (2008) 133:775&#x2013;87. doi:&#xa0;10.1016/j.cell.2008.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.05.009</ArticleId><ArticleId IdType="pubmed">18510923</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol (2007) 7:875&#x2013;88. doi:&#xa0;10.1038/nri2189</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2189</ArticleId><ArticleId IdType="pubmed">17948021</ArticleId></ArticleIdList></Reference><Reference><Citation>Proschinger S, Winker M, Joisten N, Bloch W, Palmowski J, Zimmer P. The effect of exercise on regulatory T cells: A systematic review of human and animal studies with future perspectives and methodological recommendations. Exerc Immunol Rev (2021) 27:142&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">33965900</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein L, Robey EA, Hsieh C-S. Central CD4+ T cell tolerance: deletion versus regulatory T cell differentiation. Nat Rev Immunol (2019) 19:7&#x2013;18. doi:&#xa0;10.1038/s41577-018-0083-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0083-6</ArticleId><ArticleId IdType="pubmed">30420705</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, Mikami N, Wing JB, Tanaka A, Ichiyama K, Ohkura N. Regulatory T cells and human disease. Annu Rev Immunol (2020) 38:1&#x2013;26. doi:&#xa0;10.1146/annurev-immunol-042718-041717</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042718-041717</ArticleId><ArticleId IdType="pubmed">32017635</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol (2010) 10:490&#x2013;500. doi:&#xa0;10.1038/nri2785</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2785</ArticleId><ArticleId IdType="pubmed">20559327</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum MD, Way SS, Abbas AK. Regulatory T cell memory. Nat Rev Immunol (2016) 16:90&#x2013;101. doi:&#xa0;10.1038/nri.2015.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2015.1</ArticleId><ArticleId IdType="pmc">PMC5113825</ArticleId><ArticleId IdType="pubmed">26688349</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol (2008) 8:523&#x2013;32. doi:&#xa0;10.1038/nri2343</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2343</ArticleId><ArticleId IdType="pmc">PMC2665249</ArticleId><ArticleId IdType="pubmed">18566595</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol (2018) 19:665&#x2013;73. doi:&#xa0;10.1038/s41590-018-0120-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0120-4</ArticleId><ArticleId IdType="pmc">PMC7882196</ArticleId><ArticleId IdType="pubmed">29925983</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z. Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev (2011) 10:744&#x2013;55. doi:&#xa0;10.1016/j.autrev.2011.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.05.004</ArticleId><ArticleId IdType="pubmed">21621000</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang Z, Cao W, Wu Q, Yuan Y, Zhang X. Regulatory T cells in COVID-19. Aging Dis (2021) 12:1545&#x2013;53. doi:&#xa0;10.14336/ad.2021.0709</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/ad.2021.0709</ArticleId><ArticleId IdType="pmc">PMC8460308</ArticleId><ArticleId IdType="pubmed">34631206</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zheng J, Islam MS, Yang Y, Hu Y, Chen X. The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment. Int J Biol Sci (2021) 17:1507&#x2013;20. doi:&#xa0;10.7150/ijbs.59534</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59534</ArticleId><ArticleId IdType="pmc">PMC8071774</ArticleId><ArticleId IdType="pubmed">33907514</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahimzadeh M, Naderi N. Toward an understanding of regulatory T cells in COVID-19: A systematic review. J Med Virol (2021) 93:4167&#x2013;81. doi:&#xa0;10.1002/jmv.26891</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26891</ArticleId><ArticleId IdType="pubmed">33605463</ArticleId></ArticleIdList></Reference><Reference><Citation>Alahyari S, Rajaeinejad M, Jalaeikhoo H, Amani D. Regulatory T cells in immunopathogenesis and severity of COVID-19: A systematic review. Arch Iran Med (2021) 25:127&#x2013;32. doi:&#xa0;10.34172/aim.2022.22</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/aim.2022.22</ArticleId><ArticleId IdType="pubmed">35429952</ArticleId></ArticleIdList></Reference><Reference><Citation>Madonna G, Sale S, Capone M, Falco CD, Santocchio V, Matola TD, et al. . Clinical outcome prediction in COVID-19 patients by lymphocyte subsets analysis and monocytes&#x2019; iTNF-&#x3b1; expression. Biology (2021) 10:735. doi:&#xa0;10.3390/biology10080735</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10080735</ArticleId><ArticleId IdType="pmc">PMC8389652</ArticleId><ArticleId IdType="pubmed">34439967</ArticleId></ArticleIdList></Reference><Reference><Citation>Sami R, Fathi F, Eskandari N, Ahmadi M, ArefNezhad R, Motedayyen H. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Cytokine (2021) 140:155439. doi:&#xa0;10.1016/j.cyto.2021.155439</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155439</ArticleId><ArticleId IdType="pmc">PMC7837287</ArticleId><ArticleId IdType="pubmed">33524886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi A, Tahmasebi S, Mahmood A, Kuznetsova M, Valizadeh H, Taghizadieh A, et al. . Th17 and treg cells function in SARS-CoV2 patients compared with healthy controls. J Cell Physiol (2021) 236:2829&#x2013;39. doi:&#xa0;10.1002/jcp.30047</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30047</ArticleId><ArticleId IdType="pubmed">32926425</ArticleId></ArticleIdList></Reference><Reference><Citation>Caldrer S, Mazzi C, Bernardi M, Prato M, Ronzoni N, Rodari P, et al. . Regulatory T cells as predictors of clinical course in hospitalised COVID-19 patients. Front Immunol (2021) 12:789735. doi:&#xa0;10.3389/fimmu.2021.789735</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.789735</ArticleId><ArticleId IdType="pmc">PMC8674838</ArticleId><ArticleId IdType="pubmed">34925369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya H, Usuda D. Duration from onset to discharge is longer in COVID-19 patients with low blood regulatory T-cell counts. J Med Virol (2022) 94:840&#x2013;1. doi:&#xa0;10.1002/jmv.27401</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27401</ArticleId><ArticleId IdType="pmc">PMC8662246</ArticleId><ArticleId IdType="pubmed">34661300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. T-Cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis. Front Immunol (2020) 11:589380. doi:&#xa0;10.3389/fimmu.2020.589380</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.589380</ArticleId><ArticleId IdType="pmc">PMC7596772</ArticleId><ArticleId IdType="pubmed">33178221</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhafiz AS, Fouad MA, Sayed-Ahmed MM, Kamel MM, Ali A, Fouda M, et al. . Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients. Virology (2021) 563:74&#x2013;81. doi:&#xa0;10.1016/j.virol.2021.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2021.08.012</ArticleId><ArticleId IdType="pmc">PMC8397927</ArticleId><ArticleId IdType="pubmed">34478955</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohebbi SR, Baghaei K, Rostami-Nejad M, Mojarad EN, Mirjalali H, Yadegar A, et al. . Significant changes of CD4, FOXP3, CD25, and IL6 expression level in Iranian COVID-19 patients. Gastroenterol Hepatol Bed Bench (2020) 13:388&#x2013;92. doi:&#xa0;10.22037/ghfbb.v13i4.2157</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/ghfbb.v13i4.2157</ArticleId><ArticleId IdType="pmc">PMC7682958</ArticleId><ArticleId IdType="pubmed">33244382</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med (2022) 28:911&#x2013;23. doi:&#xa0;10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Lillie E, Zarin W, O&#x2019;Brien KK, Colquhoun H, Levac D, et al. . PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med (2018) 169:467&#x2013;73. doi:&#xa0;10.7326/m18-0850</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Pe&#xf1;a S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, et al. . Profound treg perturbations correlate with COVID-19 severity. Proc Natl Acad Sci (2021) 118:e2111315118. doi:&#xa0;10.1073/pnas.2111315118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2111315118</ArticleId><ArticleId IdType="pmc">PMC8449354</ArticleId><ArticleId IdType="pubmed">34433692</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gasalla M, Berman-Riu M, Pons J, Rodr&#xed;guez A, Iglesias A, Mart&#xed;nez-Pomar N, et al. . Hyperinflammatory state and low T1 adaptive immune response in severe and critical acute COVID-19 patients. Front Med (2022) 9:828678. doi:&#xa0;10.3389/fmed.2022.828678</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.828678</ArticleId><ArticleId IdType="pmc">PMC9002349</ArticleId><ArticleId IdType="pubmed">35425776</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann AD, Weinberg SE, Swaminathan S, Chaudhuri S, Mubarak HF, Schipma MJ, et al. . Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients. Biorxiv (2022). doi:&#xa0;10.1101/2022.03.26.485922</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.26.485922</ArticleId><ArticleId IdType="pmc">PMC10162478</ArticleId><ArticleId IdType="pubmed">37150240</ArticleId></ArticleIdList></Reference><Reference><Citation>Khesht AMS, Karpisheh V, Saeed BQ, Zekiy AO, Yapanto LM, Afjadi MN, et al. . Different T cell related immunological profiles in COVID-19 patients compared to healthy controls. Int Immunopharmacol (2021) 97:107828. doi:&#xa0;10.1016/j.intimp.2021.107828</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107828</ArticleId><ArticleId IdType="pmc">PMC8162824</ArticleId><ArticleId IdType="pubmed">34091116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostopoulos IV, Orologas-Stavrou N, Rousakis P, Panteli C, Ntanasis-Stathopoulos I, Charitaki I, et al. . Recovery of innate immune cells and persisting alterations in adaptive immunity in the peripheral blood of convalescent plasma donors at eight months post SARS-CoV-2 infection. Microorg (2021) 9:546. doi:&#xa0;10.3390/microorganisms9030546</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9030546</ArticleId><ArticleId IdType="pmc">PMC8000115</ArticleId><ArticleId IdType="pubmed">33800807</ArticleId></ArticleIdList></Reference><Reference><Citation>Orologas-Stavrou N, Politou M, Rousakis P, Kostopoulos IV, Ntanasis-Stathopoulos I, Jahaj E, et al. . Peripheral blood immune profiling of convalescent plasma donors reveals alterations in specific immune subpopulations even at 2 months post SARS-CoV-2 infection. Viruses (2020) 13:26. doi:&#xa0;10.3390/v13010026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010026</ArticleId><ArticleId IdType="pmc">PMC7824046</ArticleId><ArticleId IdType="pubmed">33375675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzer B, Trapin D, Ettel P, K&#xf6;rm&#xf6;czi U, Rottal A, Tuppy F, et al. . Immunological imprint of COVID-19 on human peripheral blood leukocyte populations. Allergy (2021) 76:751&#x2013;65. doi:&#xa0;10.1111/all.14647</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14647</ArticleId><ArticleId IdType="pmc">PMC7984452</ArticleId><ArticleId IdType="pubmed">33128792</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yang X, Wang H, Li Z, Deng H, Liu J, et al. . Analysis of the long-term impact on cellular immunity in COVID-19-Recovered individuals reveals a profound NKT cell impairment. Mbio (2021) 12:e00085-21. doi:&#xa0;10.1128/mbio.00085-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.00085-21</ArticleId><ArticleId IdType="pmc">PMC8092197</ArticleId><ArticleId IdType="pubmed">33906918</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrara MR, Bonfante F, Costenaro P, Cantarutti A, Carmona F, Ruffoni E, et al. . Asymptomatic and mild SARS-CoV-2 infections elicit lower immune activation and higher specific neutralizing antibodies in children than in adults. Front Immunol (2021) 12:741796. doi:&#xa0;10.3389/fimmu.2021.741796</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.741796</ArticleId><ArticleId IdType="pmc">PMC8515185</ArticleId><ArticleId IdType="pubmed">34659235</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajamanickam A, Kumar NP, Pandiaraj AN, Selvaraj N, Munisankar S, Renji RM, et al. . Characterization of memory T cell subsets and common &#x3b3;&#x2013;chain cytokines in convalescent COVID-19 individuals. J Leukocyte Biol (2022) 112:201&#x2013;12. doi:&#xa0;10.1002/jlb.5cova0721-392rr</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.5cova0721-392rr</ArticleId><ArticleId IdType="pmc">PMC9088480</ArticleId><ArticleId IdType="pubmed">35258122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med (2022) 20:26. doi:&#xa0;10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa HA, Shaw TN, Knight SB, Wemyss K, McClure FA, Pearmain L, et al. . Alterations in T and b cell function persist in convalescent COVID-19 patients. Med (2021) 2:720&#x2013;735.e4. doi:&#xa0;10.1016/j.medj.2021.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Taeschler P, Adamo S, Deng Y, Cervia C, Zurbuchen Y, Chevrier S, et al. . T-Cell recovery and evidence of persistent immune activation 12 months after severe COVID-19. Allergy (2022) 77:10. doi:&#xa0;10.1111/all.15372</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15372</ArticleId><ArticleId IdType="pmc">PMC9347640</ArticleId><ArticleId IdType="pubmed">35567391</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M, Chroscicki P, Swatler J, Stepnik D, Biasi SD, Hampel M, et al. . Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front Immunol (2022) 13:886431. doi:&#xa0;10.3389/fimmu.2022.886431</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M, Vig&#xf3;n L, Fuertes D, Murciano-Ant&#xf3;n MA, Casado-Fern&#xe1;ndez G, Dom&#xed;nguez-Mateos S, et al. . Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: Identification of diagnostic biomarkers. Front Immunol (2022) 13:848886. doi:&#xa0;10.3389/fimmu.2022.848886</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, et al. . Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol (2021) 12:700782. doi:&#xa0;10.3389/fimmu.2021.700782</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Ruiz-Ruig&#xf3;mez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, Gonz&#xe1;lez-Cuadrado C, et al. . A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomed (2021) 9:1540. doi:&#xa0;10.3390/biomedicines9111540</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111540</ArticleId><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W, Liu X, Cao Q, Ma P, Le W, Xie L, et al. . High-dimensional single-cell analysis reveals the immune characteristics of COVID-19. Am J Physiol-lung C (2021) 320:L84&#x2013;98. doi:&#xa0;10.1152/ajplung.00355.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00355.2020</ArticleId><ArticleId IdType="pmc">PMC7869955</ArticleId><ArticleId IdType="pubmed">33146564</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett CE, Okholm TLH, Tenvooren I, Marquez DM, Tamaki S, Sandoval PM, et al. . Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients. Immunity (2022) 55:1284&#x2013;1298.e3. doi:&#xa0;10.1016/j.immuni.2022.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.06.004</ArticleId><ArticleId IdType="pmc">PMC9170540</ArticleId><ArticleId IdType="pubmed">35779527</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo JG, Leong JY, Tay SH, Nadua KD, Anderson DE, Lim AJM, et al. . A virus-specific immune rheostat in the immunome of patients recovering from mild COVID-19. Front Immunol (2021) 12:674279. doi:&#xa0;10.3389/fimmu.2021.674279</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.674279</ArticleId><ArticleId IdType="pmc">PMC8185226</ArticleId><ArticleId IdType="pubmed">34113347</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest (2020) 130:2620&#x2013;9. doi:&#xa0;10.1172/jci137244</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Long W, Tu M, Chen S, Huang Y, Wang S, et al. . Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19. J Infection (2020) 81:318&#x2013;56. doi:&#xa0;10.1016/j.jinf.2020.03.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.054</ArticleId><ArticleId IdType="pmc">PMC7151318</ArticleId><ArticleId IdType="pubmed">32283159</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Berube J, McNamara M, Saksena S, Hartman M, Arshad T, et al. . Lymphocyte subset counts in COVID-19 patients: A meta-analysis. Cytom Part A (2020) 97:772&#x2013;6. doi:&#xa0;10.1002/cyto.a.24172</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.24172</ArticleId><ArticleId IdType="pmc">PMC7323417</ArticleId><ArticleId IdType="pubmed">32542842</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J-W, Zhang C, Fan X, Meng F-P, Xu Z, Xia P, et al. . Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun (2020) 11:3410. doi:&#xa0;10.1038/s41467-020-17240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17240-2</ArticleId><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M, et al. . The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight (2020) 5:e137799. doi:&#xa0;10.1172/jci.insight.137799</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.137799</ArticleId><ArticleId IdType="pmc">PMC7259533</ArticleId><ArticleId IdType="pubmed">32324595</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. . Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in wuhan, China. Clin Infect Dis Off Publ Infect Dis Soc Am (2020) 71:762&#x2013;8. doi:&#xa0;10.1093/cid/ciaa248</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Segundo DS, de las RFA, Lamadrid-Perojo P, Comins-Boo A, Gonz&#xe1;lez-Rico C, Alonso-Pe&#xf1;a M, et al. . Innate and adaptive immune assessment at admission to predict clinical outcome in COVID-19 patients. Biomed (2021) 9:917. doi:&#xa0;10.3390/biomedicines9080917</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080917</ArticleId><ArticleId IdType="pmc">PMC8389676</ArticleId><ArticleId IdType="pubmed">34440121</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L, et al. . Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19. Allergy (2021) 76:2866&#x2013;81. doi:&#xa0;10.1111/all.14866</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14866</ArticleId><ArticleId IdType="pmc">PMC8251365</ArticleId><ArticleId IdType="pubmed">33884644</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinhold M, Shimabukuro-Vornhagen A, Franke A, Theurich S, Wahl P, Hallek M, et al. . Physical exercise modulates the homeostasis of human regulatory T cells. J Allergy Clin Immunol (2016) 137:1607&#x2013;1610.e8. doi:&#xa0;10.1016/j.jaci.2015.10.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2015.10.035</ArticleId><ArticleId IdType="pubmed">26774657</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkura N, Yasumizu Y, Kitagawa Y, Tanaka A, Nakamura Y, Motooka D, et al. . Regulatory T cell-specific epigenomic region variants are a key determinant of susceptibility to common autoimmune diseases. Immunity (2020) 52:1119&#x2013;1132.e4. doi:&#xa0;10.1016/j.immuni.2020.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.006</ArticleId><ArticleId IdType="pubmed">32362325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkura N, Sakaguchi S. Transcriptional and epigenetic basis of treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res (2020) 30:465&#x2013;74. doi:&#xa0;10.1038/s41422-020-0324-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0324-7</ArticleId><ArticleId IdType="pmc">PMC7264322</ArticleId><ArticleId IdType="pubmed">32367041</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappelmann N, Dantzer R, Khandaker GM. Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19. Psychoneuroendocrino (2021) 131:105295. doi:&#xa0;10.1016/j.psyneuen.2021.105295</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2021.105295</ArticleId><ArticleId IdType="pmc">PMC8172271</ArticleId><ArticleId IdType="pubmed">34119855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 441:235&#x2013;8. doi:&#xa0;10.1038/nature04753</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04753</ArticleId><ArticleId IdType="pubmed">16648838</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez-Bautista JF, Rodriguez-Nicolas A, Rosales-Castillo A, Jim&#xe9;nez P, Garrido F, Anderson P, et al. . Negative clinical evolution in COVID-19 patients is frequently accompanied with an increased proportion of undifferentiated Th cells and a strong underrepresentation of the Th1 subset. Front Immunol (2020) 11:596553. doi:&#xa0;10.3389/fimmu.2020.596553</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.596553</ArticleId><ArticleId IdType="pmc">PMC7726249</ArticleId><ArticleId IdType="pubmed">33324414</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomo S, Banerjee M, Karli S, Purohit P, Mitra P, Sharma P, et al. . Assessment of DHEAS, cortisol, and DHEAS/cortisol ratio in patients with COVID-19: a pilot study. Hormones Athens Greece (2022) 21:515&#x2013;8. doi:&#xa0;10.1007/s42000-022-00382-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-022-00382-x</ArticleId><ArticleId IdType="pmc">PMC9266078</ArticleId><ArticleId IdType="pubmed">35804262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarohan AR, K&#x131;z&#x131;l M, &#x130;nkaya A&#xc7;, Mahmud S, Akram M, Cen O. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cell Signal (2021) 87:110121. doi:&#xa0;10.1016/j.cellsig.2021.110121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2021.110121</ArticleId><ArticleId IdType="pmc">PMC8380544</ArticleId><ArticleId IdType="pubmed">34438017</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvvari TK, Kutikuppala LVS, Tsagkaris C, Corriero AC, Kandi V. Post-COVID-19 complications: Multisystemic approach. J Med Virol (2021) 93:6451&#x2013;5. doi:&#xa0;10.1002/jmv.27222</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27222</ArticleId><ArticleId IdType="pmc">PMC8427008</ArticleId><ArticleId IdType="pubmed">34289162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei M, Bose D, Nouri-Vaskeh M, Tajiknia V, Zand R, Ghasemi M. Long-term side effects and lingering symptoms post COVID-19 recovery. Rev Med Virol (2021) 23:e2289. doi:&#xa0;10.1002/rmv.2289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2289</ArticleId><ArticleId IdType="pmc">PMC8646420</ArticleId><ArticleId IdType="pubmed">34499784</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, et al. . Post-COVID-19 tachycardia syndrome: A distinct phenotype of post-acute COVID-19 syndrome. Am J Med (2021) 134:1451&#x2013;6. doi:&#xa0;10.1016/j.amjmed.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.004</ArticleId><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis (2020) 100:327&#x2013;32. doi:&#xa0;10.1016/j.ijid.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang K. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology (2003) 38:1437&#x2013;48. doi:&#xa0;10.1016/j.hep.2003.09.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hep.2003.09.026</ArticleId><ArticleId IdType="pubmed">14647055</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol (2005) 6:353&#x2013;60. doi:&#xa0;10.1038/ni1181</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1181</ArticleId><ArticleId IdType="pubmed">15785761</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer O, Saadoun D, Abriol J, Dodille M, Piette J-C, Cacoub P, et al. . CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis c-mixed cryoglobulinemia vasculitis. Blood (2004) 103:3428&#x2013;30. doi:&#xa0;10.1182/blood-2003-07-2598</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-07-2598</ArticleId><ArticleId IdType="pubmed">14684420</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodr&#xed;guez Y, Zapata E, Ram&#xed;rez-Santana C, et al. . Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome. J Infect Dis (2022) 225:2155&#x2013;62. doi:&#xa0;10.1093/infdis/jiac017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. . Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study. Clin Infect Dis Off Publ Infect Dis Soc Am (2021) 74:1191&#x2013;8. doi:&#xa0;10.1093/cid/ciab611</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, Acosta-Ampudia Y, Monsalve DM, Zhu C, Li Q-Z, et al. . Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med (2022) 20:129. doi:&#xa0;10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L, et al. . Case report: Neutralization of autoantibodies targeting G-Protein-Coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med (2021) 8:754667. doi:&#xa0;10.3389/fmed.2021.754667</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuken PA, Stallmach A, Pletz MW, Brandt C, Andreas N, Hahnfeld S, et al. . Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. Leukemia (2021) 35:920&#x2013;3. doi:&#xa0;10.1038/s41375-021-01175-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41375-021-01175-8</ArticleId><ArticleId IdType="pmc">PMC7893131</ArticleId><ArticleId IdType="pubmed">33608636</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. . Persistence and evolution of SARS-CoV-2 in an immunocompromised host. New Engl J Med (2020) 383:NEJMc2031364. doi:&#xa0;10.1056/nejmc2031364</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D, Castro K, Schwarz S, Vaidy K, Rabinowitz S, Wallach T. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. Jpgn Rep (2021) 3:e152. doi:&#xa0;10.1097/pg9.0000000000000152</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pg9.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans LJ, Khan M, Yoo S-J, Zapiec B, Gerven LV, Slambrouck JV, et al. . Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir Med (2021) 9:e78&#x2013;9. doi:&#xa0;10.1016/s2213-2600(21)00240-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(21)00240-x</ArticleId><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Alter G, Walt DR. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Medrxiv (2022) 2022:6. doi:&#xa0;10.1101/2022.06.14.22276401</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.14.22276401</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Mu&#xf1;oz P, et al. . Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis (2022) 22:211. doi:&#xa0;10.1186/s12879-022-07153-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Viszlayov&#xe1; D, Sojka M, Dobrodenkov&#xe1; S, Szab&#xf3; S, Bilec O, Turzov&#xe1; M, et al. . SARS-CoV-2 RNA in the cerebrospinal fluid of a patient with long COVID. Ther Adv Infect Dis (2021) 8:20499361211048572. doi:&#xa0;10.1177/20499361211048572</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211048572</ArticleId><ArticleId IdType="pmc">PMC8511908</ArticleId><ArticleId IdType="pubmed">34659752</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Fan J, Huang J, Guo E, Fu Y, Liu S, et al. . Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection. Nat Commun (2021) 12:3501. doi:&#xa0;10.1038/s41467-021-23621-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23621-y</ArticleId><ArticleId IdType="pmc">PMC8190301</ArticleId><ArticleId IdType="pubmed">34108465</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhong M, Hong K, Yang Q, Zhang E, Zhou D, et al. . Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity &#x2013; a cohort study. Clin Transl Immunol (2021) 10:e1259. doi:&#xa0;10.1002/cti2.1259</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1259</ArticleId><ArticleId IdType="pmc">PMC7932004</ArticleId><ArticleId IdType="pubmed">33728049</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Sun R, Ge W, Mao T, Qian L, Huang C, et al. . Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA shedding. Cell Discovery (2022) 8:70. doi:&#xa0;10.1038/s41421-022-00441-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-022-00441-y</ArticleId><ArticleId IdType="pmc">PMC9311354</ArticleId><ArticleId IdType="pubmed">35879274</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg SE, Singer BD, Steinert EM, Martinez CA, Mehta MM, Mart&#xed;nez-Reyes I, et al. . Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature (2019) 565:495&#x2013;9. doi:&#xa0;10.1038/s41586-018-0846-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0846-z</ArticleId><ArticleId IdType="pmc">PMC6345596</ArticleId><ArticleId IdType="pubmed">30626970</ArticleId></ArticleIdList></Reference><Reference><Citation>Galgani M, Rosa VD, Cava AL, Matarese G. Role of metabolism in the immunobiology of regulatory T cells. J Immunol (2016) 197:2567&#x2013;75. doi:&#xa0;10.4049/jimmunol.1600242</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600242</ArticleId><ArticleId IdType="pmc">PMC5027986</ArticleId><ArticleId IdType="pubmed">27638939</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az-Resendiz KJG, Benitez-Trinidad AB, Covantes-Rosales CE, Toledo-Ibarra GA, Ortiz-Lazareno PC, Gir&#xf3;n-P&#xe9;rez DA, et al. . Loss of mitochondrial membrane potential (&#x394;&#x3a8; m) in leucocytes as post-COVID-19 sequelae. J Leukocyte Biol (2022) 112:23&#x2013;9. doi:&#xa0;10.1002/jlb.3ma0322-279rrr</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.3ma0322-279rrr</ArticleId><ArticleId IdType="pmc">PMC9088601</ArticleId><ArticleId IdType="pubmed">35355308</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E, Petrache I, Goldstein NM, Olin JT, Keith RC, Modena B, et al. . Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Resp Crit Care (2021) 205:126&#x2013;9. doi:&#xa0;10.1164/rccm.202108-1903le</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903le</ArticleId><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP. Mitochondria: In the cross fire of SARS-CoV-2 and immunity. Iscience (2020) 23:101631. doi:&#xa0;10.1016/j.isci.2020.101631</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101631</ArticleId><ArticleId IdType="pmc">PMC7524535</ArticleId><ArticleId IdType="pubmed">33015593</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci (2021) 118:e2024358118. doi:&#xa0;10.1073/pnas.2024358118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, et al. . Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med (2007) 13:423&#x2013;31. doi:&#xa0;10.1038/nm1564</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1564</ArticleId><ArticleId IdType="pmc">PMC3427780</ArticleId><ArticleId IdType="pubmed">17384649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow Z, Banerjee A, Hickey MJ. Controlling the fire &#x2014; tissue-specific mechanisms of effector regulatory T-cell homing. Immunol Cell Biol (2015) 93:355&#x2013;63. doi:&#xa0;10.1038/icb.2014.117</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.2014.117</ArticleId><ArticleId IdType="pubmed">25582339</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhao L, Lv J, Yin Q, Liang X, Chu Y, et al. . BLT1-dependent alveolar recruitment of CD4+CD25+ Foxp3+ regulatory T cells is important for resolution of acute lung injury. Am J Resp Crit Care (2012) 186:989&#x2013;98. doi:&#xa0;10.1164/rccm.201202-0261oc</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201202-0261oc</ArticleId><ArticleId IdType="pubmed">22955313</ArticleId></ArticleIdList></Reference><Reference><Citation>Burzyn D, Kuswanto W, Kolodin D, Shadrach JL, Cerletti M, Jang Y, et al. . A special population of regulatory T cells potentiates muscle repair. Cell (2013) 155:1282&#x2013;95. doi:&#xa0;10.1016/j.cell.2013.10.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.10.054</ArticleId><ArticleId IdType="pmc">PMC3894749</ArticleId><ArticleId IdType="pubmed">24315098</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J (2022) 43:1157&#x2013;72. doi:&#xa0;10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol (2020) 5:1265&#x2013;73. doi:&#xa0;10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z, Tang N, Chen Y, Ma L, Wei Y, Lu Y, et al. . CT features of COVID-19 patients with two consecutive negative RT-PCR tests after treatment. Sci Rep-uk (2020) 10:11548. doi:&#xa0;10.1038/s41598-020-68509-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68509-x</ArticleId><ArticleId IdType="pmc">PMC7360570</ArticleId><ArticleId IdType="pubmed">32665633</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R, Barreiro-Perez M, Martin-Garcia A, Almeida J, Villacorta E, Perez-Pons A, et al. . Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. Medrxiv (2020) 2020. doi:&#xa0;10.1101/2020.07.12.20151316</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.12.20151316</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslbauer JD, Zinner C, Stalder AK, Schneeberger J, Menter T, Bassetti S, et al. . Vascular damage, thromboinflammation, plasmablast activation, T-cell dysregulation and pathological histiocytic response in pulmonary draining lymph nodes of COVID-19. Front Immunol (2021) 12:763098. doi:&#xa0;10.3389/fimmu.2021.763098</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.763098</ArticleId><ArticleId IdType="pmc">PMC8710573</ArticleId><ArticleId IdType="pubmed">34966385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves-Pereira MH, Santiago L, Ravetti CG, Vassallo PF, Andrade MVM, Vieira MS, et al. . Dysfunctional phenotype of systemic and pulmonary regulatory T cells associates with lethal COVID-19 cases. Immunology (2022). doi:&#xa0;10.1111/imm.13603</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13603</ArticleId><ArticleId IdType="pmc">PMC9877711</ArticleId><ArticleId IdType="pubmed">36349514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronit A, Berg RMG, Bay JT, Haugaard AK, Ahlstr&#xf6;m MG, Burgdorf KS, et al. . Compartmental immunophenotyping in COVID-19 ARDS: A case series. J Allergy Clin Immunol (2021) 147:81&#x2013;91. doi:&#xa0;10.1016/j.jaci.2020.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.09.009</ArticleId><ArticleId IdType="pmc">PMC7581505</ArticleId><ArticleId IdType="pubmed">32979342</ArticleId></ArticleIdList></Reference><Reference><Citation>Liechti T, Roederer M. OMIP-060: 30-parameter flow cytometry panel to assess T cell effector functions and regulatory T cells. Cytom Part A (2019) 95:1129&#x2013;34. doi:&#xa0;10.1002/cyto.a.23853</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.23853</ArticleId><ArticleId IdType="pubmed">31334913</ArticleId></ArticleIdList></Reference><Reference><Citation>Santegoets SJAM, Dijkgraaf EM, Battaglia A, Beckhove P, Britten CM, Gallimore A, et al. . Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry. Cancer Immunol Immunother (2015) 64:1271&#x2013;86. doi:&#xa0;10.1007/s00262-015-1729-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00262-015-1729-x</ArticleId><ArticleId IdType="pmc">PMC4554737</ArticleId><ArticleId IdType="pubmed">26122357</ArticleId></ArticleIdList></Reference><Reference><Citation>Andeweg SP, Vennema H, Veldhuijzen I, Smorenburg N, Schmitz D, Zwagemaker F, et al. . Elevated risk of infection with SARS-CoV-2 beta, gamma, and delta variant compared to alpha variant in vaccinated individuals. Sci Transl Med (2022):eabn4338. doi:&#xa0;10.1126/scitranslmed.abn4338</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abn4338</ArticleId><ArticleId IdType="pmc">PMC9580257</ArticleId><ArticleId IdType="pubmed">35862508</ArticleId></ArticleIdList></Reference><Reference><Citation>McCallum M, Czudnochowski N, Rosen LE, Zepeda SK, Bowen JE, Walls AC, et al. . Structural basis of SARS-CoV-2 omicron immune evasion and receptor engagement. Science (2022) 375:864&#x2013;8. doi:&#xa0;10.1126/science.abn8652</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn8652</ArticleId><ArticleId IdType="pmc">PMC9427005</ArticleId><ArticleId IdType="pubmed">35076256</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, et al. . Broadly neutralizing antibodies overcome SARS-CoV-2 omicron antigenic shift. Nature (2022) 602:664&#x2013;70. doi:&#xa0;10.1038/s41586-021-04386-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04386-2</ArticleId><ArticleId IdType="pmc">PMC9531318</ArticleId><ArticleId IdType="pubmed">35016195</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds CJ, Gibbons JM, Pade C, Lin K-M, Sandoval DM, Pieper F, et al. . Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants. Science (2022) 375:183&#x2013;92. doi:&#xa0;10.1126/science.abm0811</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm0811</ArticleId><ArticleId IdType="pmc">PMC10186585</ArticleId><ArticleId IdType="pubmed">34855510</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>